Connection

Peter Horby to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Peter Horby has written about Cost-Benefit Analysis.
Peter Horby
Connection Strength
0.130
Cost-Benefit Analysis
  1. Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009. BMC Med. 2020 08 21; 18(1):265.
    View in: PubMed
    Score: 0.103
  2. Potential health and economic impacts of dexamethasone treatment for patients with COVID-19. Nat Commun. 2021 02 10; 12(1):915.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.